Patents Examined by S. L. Nolan
  • Patent number: 5128128
    Abstract: Provided are a virus vaccine, comprising a properly incapacitated virus lacking an antigen of the wild-type virus which is useful for serologically distinguished between vaccinated and infected animals, methods for distinguishing between vaccinated and infected animals and multivalent vaccines.
    Type: Grant
    Filed: February 9, 1989
    Date of Patent: July 7, 1992
    Assignee: The Upjohn Company
    Inventors: Leonard E. Post, Darrell R. Thomsen
  • Patent number: 5128256
    Abstract: Vectors are described that circumvent traditional DNA cloning and subcloning procedures, and that contain a unique DNA cartridge that permits both cloning of DNA directly into DNA sequences present within the cartridge, and in vivo removal and circularization of the cartridge thereby yielding an autonomously replicating structure. Because the DNA cartridge can include a wide variety of functional DNA sequences, the cloned DNA can be subjected to a plethora of molecular biological procedures without having to remove the cloned DNA from the cartridge thereby obviating the need to perform additional subcloning techniques. A particularly useful example of this type of vector is bacteriophage lambda containing the DNA cartridge.
    Type: Grant
    Filed: April 20, 1989
    Date of Patent: July 7, 1992
    Assignee: Stratagene
    Inventors: William Huse, Joseph A. Sorge, Jay M. Short
  • Patent number: 5126251
    Abstract: The present invention relates to a eukaryotic cell line which expresses a foreign RNA polymerase gene. The invention further relates to a method of expressing a foreign protein in a eukaryotic environment utilizing the cell line. The present invention allows for the expression of a foreign protein in a eukaryotic cell without requiring transfecting or infecting the cell with a vector carrying the RNA polymerase gene.
    Type: Grant
    Filed: March 1, 1990
    Date of Patent: June 30, 1992
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Bernard Moss, Orna Elroy-Stein
  • Patent number: 5126252
    Abstract: An improved vector upon introduction into a suitable host containing the thermolabile repressor C.sub.I renders the host capable of effecting expression of a desired gene. The vector is a double-stranded DNA molecule which includes in 5' to 3' order the following: the promoter and operator P.sub.L O.sub.L from lambda bacteriophage; the N utilization site; a first restriction enzyme site permitting replacement of the ribosomal binding site which follows thereafter; a ribosomal binding site; an ATG initiation codon or DNA which is converted into an ATG initiation codon upon insertion of the desired gene into the vector; a second restriction enzyme site for inserting the gene in phase with the ATG codon; a T.sub.1 T.sub.2 rRNA transcription termination sequence; an origin of replication and a gene associated with a selectable or identificable phenotypic trait manifested when the vector is present in the host. The distance between the 3' end of the P.sub.L O.sub.
    Type: Grant
    Filed: March 1, 1989
    Date of Patent: June 30, 1992
    Assignee: Bio-Technology General Corp.
    Inventors: Amos B. Oppenheim, Avigdor Levanon, Hilla Locker-Galadi, Marian Gorecki
  • Patent number: 5126266
    Abstract: A growth medium is provided for mutant mixtures of Pichia stipitis or Candida shehatae that permits the growth of mutants which are the best xylose-to-ethanol fermenters in the mixture while inhibiting the growth of inefficient fermenters. The medium comprises a mixture of two compounds, the first compound selected from the group consisting of L-xylose, L-arabinose, D-arabinose, glycerol, erythritol, erythrose, 5- and 6-carbon polyols such as xylitol, L-arabinitol, D-arabinitol and mannitol, and wherein the second compound is ammonium tartarate or an inorganic nitrogen source compound such as ammonium chloride or ammonium sulfate.
    Type: Grant
    Filed: May 2, 1988
    Date of Patent: June 30, 1992
    Assignee: The United States of America as represented by the Secretary of Agriculture
    Inventors: Thomas W. Jeffries, Philip L. Livingston
  • Patent number: 5122464
    Abstract: Recombinant DNA sequences which encode the complete amino acid sequence of a glutamine synthetase, vectors containing such sequences, and methods for their use, in particular as dominant selectable markers, for use in co-amplificiation of non-selected genes and in transforming host cell lines to glutamine independence.
    Type: Grant
    Filed: October 10, 1990
    Date of Patent: June 16, 1992
    Assignees: Celltech Limited, a British Company, The University Court of the University of Glasgow
    Inventors: Richard H. Wilson, Christopher R. Bebbington
  • Patent number: 5118616
    Abstract: A method of producing useful substances which comprising propagating in cultured cells or in a host a recombinant Bombyx mori nuclear polydegrosis virus (BmNPV) DNA is disclosed. The BmNPV DNA is produced by recombination with a double-stranded DNA containing (i) a 5'-upstream BmNPV DNA fragment orginally occurring upstream from the structural gene coding for the production of polyhedral protein and also including the promoter region for the structural gene, (ii) a translational start codon and (iii) a gene coding for the production of a useful substance exogenous to the virus, with or without (iv) a 3'-downstream BmNPV DNA fragment originally occurring downstream from the structural gene coding for the production of polyhedral protein.
    Type: Grant
    Filed: April 12, 1991
    Date of Patent: June 2, 1992
    Assignee: Daiichi Seiyaku Co., Ltd.
    Inventors: Susumu Maeda, Mitsuru Furusawa
  • Patent number: 5118615
    Abstract: Disclosed is a DNA fragment comprising a base sequence coding for a peptide occurring in human atrium cordis and having diuretic action or a precursor of the peptide, plasmids containing the DNA fragment, microorganisms transformed with the plasmid, and a process for production of the peptide using the transformant.Also disclosed is a new peptide consisting of 126 amino acids occurring in human atrium cordis and a precursor thereof. The peptide has notable diuretic action and hypotensive or antihypertensive actions.
    Type: Grant
    Filed: March 9, 1987
    Date of Patent: June 2, 1992
    Assignee: Suntory Limited
    Inventors: Hisayuki Matsuo, Kenji Kangawa, Yujiro Hayashi, Shinzo Oikawa, Takehiro Oshima, Shoji Tanaka, Hiroshi Nakazato, Yasunori Tawaragi
  • Patent number: 5112744
    Abstract: An improved vector upon introduction into a suitable host containing the thermolabile repressor C.sub.I renders the host capable of effecting expression of a desired gene. The vector is a double-stranded DNA molecule which includes in 5' to 3' order the following: the promoter and operator P.sub.L O.sub.L from lambda bacteriophage; the N utilization site; a first restriction enzyme site permitting replacement of the ribosomal binding site which follows thereafter; a ribosomal binding site; and ATG initiation codon or DNA which is converted into and ATG initiation codon upon insertion of the desired gene into the vector; a second restriction enzyme site for inserting the gene in phase with the ATG codon; a T.sub.1 T.sub.2 rRNA transcription termination sequence; and origin of replication and a gene associated with a selectable or identifiable phenotypic trait manifested when the vector is present in the host. The distance between the 3' end of the P.sub.L O.sub.
    Type: Grant
    Filed: June 15, 1990
    Date of Patent: May 12, 1992
    Assignee: Bio-Technology General Corp.
    Inventors: Amos B. Oppenheim, Avigdor Levanon, Hilla Locker-Galadi, Marian Gorecki
  • Patent number: 5110729
    Abstract: Recombinant Bombyx mori nuclear polyhedrosis viruses having, in the polyhedral protein-encoding structural gene portion of the Bombyx mori nuclear polyhedrosis virus DNA (BmNPV DNA), a structural gene for a desired protein as joined to the whole of or a part of the polyhedral protein-encoding structural gene with or without interposition of a linker base sequence are provided.By propagating the above viruses in silkworm-derived cells or silkworms, fused proteins of a desired protein and the whole of or a part of the polyhedral protein as joined together with or without interposition of a linking amino acid or peptide are produced. The desired proteins can be obtained from the fused proteins by cleavage or decomposition at the linking site.
    Type: Grant
    Filed: January 16, 1991
    Date of Patent: May 5, 1992
    Assignee: Daiichi Seiyaku Co., Ltd.
    Inventors: Susumu Maeda, Mitsuru Furusawa, Yasumasa Marumoto, Tadashi Horiuchi, Yoshinari Sato, Yoshiyuki Saeki
  • Patent number: 5106733
    Abstract: Cloning and expression of DNA segments encoding bovine GM-CSF, and processes for producing recombinant bovine GM-CSF as a product of recombinant cell culture, are disclosed.
    Type: Grant
    Filed: May 22, 1989
    Date of Patent: April 21, 1992
    Assignee: Immunex Corporation
    Inventors: Paul E. Baker, Douglas P. Cerretti, William R. Clevenger, David J. Cosman, Charles R. Maliszewski
  • Patent number: 5102802
    Abstract: A cloned DNA sequence encoding T3 RNA polymerase is provided. This DNA can be inserted into an expression vector for recombinant expression of the peptide. The peptide can be used with dual promotor vectors containing T3 specific promoters.
    Type: Grant
    Filed: January 2, 1991
    Date of Patent: April 7, 1992
    Assignee: University of Medicine and Dentistry of New Jersey
    Inventor: William T. McAllister
  • Patent number: 5096823
    Abstract: The present invention relates, in particular, to a DNA sequence corresponding to one of the following genes involved in the chain of biotin biosynthesis in bacteria: bioA gene, bioD gene, bioF, bioC and bioH gene.Vectors containing these sequences enable other microorganisms to be transformed in order to improve the production of biotin.
    Type: Grant
    Filed: September 30, 1987
    Date of Patent: March 17, 1992
    Assignee: Transgene S.A.
    Inventors: Remi Gloeckler, Denis Speck, Yves Lemoine
  • Patent number: 5094945
    Abstract: Enhanced resistance to glyphosate, an inhibitor of the aromatic amino acid biosynthesis pathway, is imparted to a glyphosate sensitive host. A mutated aroA gene is employed which expresses 5-enolpyruvyl-3-phosphoshikimate synthase (EC: 2.5.1.19) (ES-3-P synthase). Methods are provided for obtaining the aroA mutation which provides the enzyme resistant to inhibition by glyphosate, means for introducing the structural gene into a sensitive host, as well as providing a method of producing the enzyme.The E. coli strain C600 (pPMG1) has been deposited at the A.T.C.C. on December 14, 1982 and given A.T.C.C. Accession No. 39256.
    Type: Grant
    Filed: August 30, 1988
    Date of Patent: March 10, 1992
    Assignee: Calgene, Inc.
    Inventor: Luca Comai
  • Patent number: 5094951
    Abstract: The present invention provides recombinant polynucleotides which encode glucose oxidase (GO). It also provides recombinant expression systems which produce, and when desired, secrete active GO and GO analogs into the extracellular medium.
    Type: Grant
    Filed: June 19, 1989
    Date of Patent: March 10, 1992
    Assignee: Chiron Corporation
    Inventor: Steven Rosenberg
  • Patent number: 5091179
    Abstract: The invention is a method for destroying Phthorimaea operculella by causing the Phthorimaea operculella to ingest the baculorirus of the nuclear polyhedrose of the noctuid Mamestra brassicae.
    Type: Grant
    Filed: December 9, 1988
    Date of Patent: February 25, 1992
    Assignee: Calliope S.A.
    Inventors: Gerard A. Biache, Michel R. Guillon
  • Patent number: 5089408
    Abstract: DNA which encodes at least a polypeptide containing glutathione peroxidase activity and having an amino acid sequence from the N-terminal to the C-terminal of the formula: ##STR1## wherein * * * is selenocystein, is produced by culturing transformant host cells which possess extraneous DNA encoding a polypeptide with glutathione peroxidase activity in a medium containing selenium, and separating a thus-produced polypeptide with glutathione peroxidase activity from the cultured mass.
    Type: Grant
    Filed: June 15, 1989
    Date of Patent: February 18, 1992
    Assignee: Toyo Jozo Kabushiki Kaisha
    Inventors: Masami Akasaka, Akiko Kubota, Junzo Mizoguchi, Sakae Satoh
  • Patent number: 5087568
    Abstract: A process for producing recombinant human Cu, Zn-superoxide dismutase, which comprises treating a solution of copper-free or copper-deficient recombinant human Cu, Zn-superoxide dismutase with a copper salt in the presence of .beta.-mercaptoethanol.
    Type: Grant
    Filed: February 11, 1988
    Date of Patent: February 11, 1992
    Assignee: UBE Industries, Ltd.
    Inventors: Kiyoshi Fukui, Fumio Kubo, Masayuki Watanabe
  • Patent number: 5084383
    Abstract: Residual extracellular protease activities of a Bacillus subtilis strain can be further reduced by introducing a gene for the stimulation of extracellular protease levels into the genomic DNA of the strain.The resultant strain whose extracellular protease activities are further reduced is transformed with a recombinant plasmid for secretion of a desired protein and the desired protein can be efficiently produced and accumulated in the culture medium in a large amount. The accumulated desired protein can be easily recovered from the culture medium.For example, the accumulation level of human growth hormone secreted by a B. subtilis MT-430 strain carrying recombinant DNA phGH427 for the expression and secretion of human growth hormone can be increased five to tenfold as a result of the above treatment for reduction of the residual extracellular protease activities of the extracellular protease-activity-deficient strain.
    Type: Grant
    Filed: July 18, 1990
    Date of Patent: January 28, 1992
    Assignees: Agency of Industrial Science and Technology, Ministry of International Trade and Industry
    Inventors: Yoshio Furutani, Masaru Honjo, Akira Nakayama, Koichi Kawamura, Hiroaki Shimada, Izumi Mita, Akiko Akaoka
  • Patent number: 5082781
    Abstract: A novel .beta.-amylase gene is provided. This gene is useful for production of a thermophilic .beta.-amylase obtained from Clostridium thermosulfurogenes on a large scale, especially from genetically engineered microorganisms introduced with this gene. B. subtilis was transformed with a plasmid pNK1 containing the above gene and the transformed B. subtilis cells produced .beta.-amylase having the same thermostability as that of .beta.-amylase obtained from C. thermosulfurogenes.
    Type: Grant
    Filed: November 9, 1990
    Date of Patent: January 21, 1992
    Assignee: Shigezo Udaka
    Inventors: Hideo Yamagata, Noriyuki Kitamoto, Takeo Kato, Norihiro Tsukagoshi, Shigezo Udaka